MRNA
Moderna, Inc.NASDAQHealthcare$49.20-1.66%OpenMarket Cap: $19.43B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.23
P/S
10.00
EV/EBITDA
-7.35
DCF Value
$-1.51
FCF Yield
-10.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
14.1%
Operating Margin
-158.2%
Net Margin
-145.2%
ROE
-30.1%
ROA
-22.9%
ROIC
-29.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $678.0M | 33.3% | $-857.0M | $-826.0M | $-2.11 | — |
| FY 2025 | $1.94B | 55.3% | $-3.07B | $-2.82B | $-7.26 | — |
| Q3 2025 | $1.02B | 0.8% | $-260.0M | $-200.0M | $-0.51 | — |
| Q2 2025 | $142.0M | 16.2% | $-907.0M | $-825.0M | $-2.13 | — |
| Q1 2025 | $107.0M | 15.9% | $-1.05B | $-971.0M | $-2.52 | — |
| Q4 2024 | $956.0M | 22.7% | $-1.25B | $-1.12B | $-2.91 | — |
| FY 2024 | $3.20B | 54.2% | $-3.94B | $-3.56B | $-9.27 | — |
| Q3 2024 | $1.85B | 72.3% | $-70.0M | $13.0M | $0.03 | — |
| Q2 2024 | $221.0M | 48.0% | $-1.36B | $-1.28B | $-3.33 | — |
| Q1 2024 | $167.0M | 42.5% | $-1.27B | $-1.18B | $-3.08 | — |
| Q4 2023 | $2.81B | 67.0% | $6.0M | $217.0M | $0.55 | — |
| FY 2023 | $6.85B | 31.5% | $-4.24B | $-4.71B | $-12.34 | — |